UnitedHealth Group Incorporated $UNH Stake Reduced by Beverly Hills Private Wealth LLC

Beverly Hills Private Wealth LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,141 shares of the healthcare conglomerate’s stock after selling 514 shares during the quarter. Beverly Hills Private Wealth LLC’s holdings in UnitedHealth Group were worth $3,164,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in UNH. Sentry Investment Management LLC boosted its position in UnitedHealth Group by 38.4% during the 2nd quarter. Sentry Investment Management LLC now owns 4,170 shares of the healthcare conglomerate’s stock worth $1,283,000 after acquiring an additional 1,157 shares during the period. Eos Management L.P. bought a new position in UnitedHealth Group in the 2nd quarter valued at about $1,511,000. Swan Global Investments LLC raised its position in shares of UnitedHealth Group by 101.9% during the 2nd quarter. Swan Global Investments LLC now owns 1,147 shares of the healthcare conglomerate’s stock worth $358,000 after buying an additional 579 shares in the last quarter. Cidel Asset Management Inc. boosted its holdings in shares of UnitedHealth Group by 20.7% in the second quarter. Cidel Asset Management Inc. now owns 6,511 shares of the healthcare conglomerate’s stock valued at $2,031,000 after acquiring an additional 1,118 shares in the last quarter. Finally, Crux Wealth Advisors raised its holdings in UnitedHealth Group by 10.6% during the second quarter. Crux Wealth Advisors now owns 2,002 shares of the healthcare conglomerate’s stock worth $625,000 after purchasing an additional 192 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a research note on Wednesday, October 8th. Jefferies Financial Group raised their price objective on shares of UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research report on Friday. Mizuho increased their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, Robert W. Baird restated an “underperform” rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Eighteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $385.13.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $356.53 on Monday. The stock has a market cap of $322.90 billion, a PE ratio of 15.45, a price-to-earnings-growth ratio of 2.31 and a beta of 0.47. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The business has a fifty day simple moving average of $329.38 and a 200-day simple moving average of $342.24.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.